Quantbot Technologies’s Beam Therapeutics BEAM Stock Holding History

Quantbot Technologies’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,800	Closed	-$92.5K	–	1444
2024 Q1	$92.5K	Buy	+2,800	New	+$87.2K	0.01%	1197
2023 Q3	–	Sell	-3,400	Closed	-$109K	–	1543
2023 Q2	$109K	Buy	+3,400	New	+$110K	0.01%	1157
2023 Q1	–	Sell	-5,193	Closed	-$203K	–	1555
2022 Q4	$203K	Buy	5,193 +4,884	+1,581%	+$219K	0.01%	895
2022 Q3	$14K	Sell	309 -10,991	-97%	-$627K	﹤0.01%	1395
2022 Q2	$437K	Sell	11,300 -961	-8%	-$38.2K	0.04%	624
2022 Q1	$702K	Buy	12,261 +11,583	+1,708%	+$760K	0.06%	456
2021 Q4	$54K	Sell	678 -2,717	-80%	-$233K	﹤0.01%	1003
2021 Q3	$295K	Buy	+3,395	New	+$341K	0.02%	724

Other funds holding BEAM

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Quantbot Technologies's BEAM Position: Q2 2024 in Review

Quantbot Technologies sold out of Beam Therapeutics (BEAM) in Q2 2024, closing a stake of 2,800 shares — an estimated $92.5K sold.

Quantbot Technologies first reported a position in BEAM in Q3 2021 and held it in 8 quarters. The position peaked at $702K in Q1 2022. 214 funds tracked by Wall St. Rank hold BEAM as of Q2 2024.

Quantbot Technologies reported no remaining Beam Therapeutics position as of Q2 2024 after selling out during the quarter.
Quantbot Technologies sold 2,800 Beam Therapeutics shares in Q2 2024, an estimated $92.5K.
Quantbot Technologies first reported a position in Beam Therapeutics in Q3 2021 and held it in 8 quarters.
Quantbot Technologies's Beam Therapeutics position peaked at $702K in Q1 2022.
214 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2024.

Based on Quantbot Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.